Literature DB >> 19673037

Epidermal growth factor receptor protein expression and gene amplification in normal, hyperplastic, and cancerous glottic tissue: immunohistochemical and fluorescent in situ hybridization study on tissue microarrays.

Tamara Braut1, Mira Krstulja, Milodar Kujundzić, Dubravko Manestar, Ita Hadzisejdić, Nives Jonjić, Blazenka Grahovac, Darko Manestar.   

Abstract

AIM: To evaluate the importance of epidermal growth factor receptor (EGFR) protein overexpression and gene amplification in carcinogenesis of glottic cancer.
METHOD: In order to evaluate EGFR expression at protein and gene level, immunohistochemical (IHC) analysis and fluorescent in situ hybridization (FISH) were performed on tissue microarrays of laryngeal tissue (145 samples) -- 38 samples of normal mucosa, 46 samples of hyperplastic lesions, and 61 samples of cancerous lesions.
RESULTS: Membranous (mEGFR) and cytoplasmic (cEGFR) EGFR expression was significantly different between the analyzed groups. The differences were most striking in the suprabasal-transforming zone. IHC evaluation showed that high and low mEGFR staining contributed to the differentiation of dysplastic lesions, simple hyperplasia, and cancerous tissue, as well as between different degrees of atypia in hyperplastic lesions (P<0.050). EGFR gene amplification was not found in simple and abnormal hyperplastic lesions, but it was confirmed in 2/21 atypical hyperplasias, indicating that gene amplification can facilitate identification of malignant potential in hyperplastic lesions. In cancerous tissue, EGFR gene amplification was found in 8/50 samples. EGFR gene amplification was found in preinvasive cancer in one patient. In invasive carcinomas, gene amplification was not associated with stage or grade. Carcinomas with gene amplification showed significantly higher cEGFR expression (basal layer P=0.003; suprabasal layer P=0.002).
CONCLUSIONS: This study confirmed an increase in EGFR protein expression and gene amplification with the increase in biological aggressiveness of glottic lesions. A correlation between EGFR gene amplification and protein expression was established. Gene amplification proved to be an early event in glottic carcinogenesis, indicating its importance for glottic cancer prevention, early detection, and protocol selection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19673037      PMCID: PMC2728382          DOI: 10.3325/cmj.2009.50.370

Source DB:  PubMed          Journal:  Croat Med J        ISSN: 0353-9504            Impact factor:   1.351


  33 in total

1.  Tissue microarray analysis of EGFR and HER2 oncogene copy number alterations in squamous cell carcinoma of the larynx.

Authors:  Denitsa Krasimirova Koynova; Vesselina Sainova Tsenova; Renata Stoiancho Jankova; Plamen Borisov Gurov; Draga Ivanova Toncheva
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-08       Impact factor: 4.553

2.  Aberrant EGFR and chromosome 7 associate with outcome in laryngeal cancer.

Authors:  Larry E Morrison; Kristine K Jacobson; Michael Friedman; James W Schroeder; John S Coon
Journal:  Laryngoscope       Date:  2005-07       Impact factor: 3.325

3.  Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study.

Authors:  Fred R Hirsch; Marileila Varella-Garcia; Jason McCoy; Howard West; Ana Carolina Xavier; Paul Gumerlock; Paul A Bunn; Wilbur A Franklin; John Crowley; David R Gandara
Journal:  J Clin Oncol       Date:  2005-07-05       Impact factor: 44.544

4.  Criteria for grading in the Ljubljana classification of epithelial hyperplastic laryngeal lesions. A study by members of the Working Group on Epithelial Hyperplastic Laryngeal Lesions of the European Society of Pathology.

Authors:  H Hellquist; A Cardesa; N Gale; V Kambic; L Michaels
Journal:  Histopathology       Date:  1999-03       Impact factor: 5.087

5.  Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck.

Authors:  Jong Woo Lee; Young Hwa Soung; Su Young Kim; Hyo Kyung Nam; Won Sang Park; Suk Woo Nam; Min Sik Kim; Dong Il Sun; Youn Soo Lee; Ja June Jang; Jung Young Lee; Nam Jin Yoo; Sug Hyung Lee
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

Review 6.  Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions.

Authors:  William Pao; Vincent A Miller
Journal:  J Clin Oncol       Date:  2005-03-14       Impact factor: 44.544

7.  Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study.

Authors:  Mauro Moroni; Silvio Veronese; Silvia Benvenuti; Giovanna Marrapese; Andrea Sartore-Bianchi; Federica Di Nicolantonio; Marcello Gambacorta; Salvatore Siena; Alberto Bardelli
Journal:  Lancet Oncol       Date:  2005-05       Impact factor: 41.316

8.  Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions.

Authors:  T Krecicki; M Jeleń; M Zalesska-Krecicka; J Rak; T Szkudlarek; J Jeleń-Krzeszewska
Journal:  Oral Oncol       Date:  1999-03       Impact factor: 5.337

Review 9.  TNM staging of cancers of the head and neck: striving for uniformity among diversity.

Authors:  Snehal G Patel; Jatin P Shah
Journal:  CA Cancer J Clin       Date:  2005 Jul-Aug       Impact factor: 508.702

10.  Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer.

Authors:  Xavier Pivot; Nicolas Magné; Emmanuel Guardiola; Gilles Poissonnet; Olivier Dassonville; Mireille Francoual; Jean-Louis Formento; René-Jean Bensadoun; François Demard; Maurice Schneider; Gérard Milano
Journal:  Oral Oncol       Date:  2005-03       Impact factor: 5.337

View more
  2 in total

Review 1.  Emerging drugs to treat squamous cell carcinomas of the head and neck.

Authors:  Christopher Fung; Jennifer R Grandis
Journal:  Expert Opin Emerg Drugs       Date:  2010-09       Impact factor: 4.191

2.  Prognostic impact and potential interaction of EGFR and c-Met in the progression of esophageal squamous cell carcinoma.

Authors:  Haixing Wang; Dongxian Jiang; Qi Song; Chen Xu; Yuan Shi; Xiaojing Li; Jie Huang; Yifan Xu; Akesu Sujie; Haiying Zeng; Yunshi Zhong; Lijie Tan; Yingyong Hou
Journal:  Tumour Biol       Date:  2016-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.